Related Experiment Videos
Concomitant pulmonary tuberculosis and leprosy.
Han N Lee1, Colleen S Embi, Karen M Vigeland
1Department of Dermatology, Oregon Health Science University, Portland, Oregon 97201, USA.
Journal of the American Academy of Dermatology
|September 27, 2003
Summary
Concomitant tuberculosis and leprosy is rare, even in endemic areas. This case highlights a borderline lepromatous leprosy diagnosis during pulmonary tuberculosis treatment, confirmed by histopathology and Fite-Farraco stain.
Area of Science:
- Infectious Diseases
- Dermatology
- Microbiology
Background:
- Concomitant infections with tuberculosis (TB) and leprosy are infrequently reported, posing diagnostic challenges.
- Leprosy, caused by Mycobacterium leprae, and TB, caused by Mycobacterium tuberculosis, are both significant global health issues, particularly in endemic regions.
- Understanding co-infections is crucial for effective patient management and public health strategies.
Observation:
- A case report detailing a patient presenting with borderline lepromatous leprosy and a type 1 reversal reaction.
- The patient was concurrently undergoing treatment for pulmonary tuberculosis at the time of leprosy diagnosis.
- This presentation underscores the complexity of diagnosing co-existing mycobacterial infections.
Findings:
- The diagnosis of borderline lepromatous leprosy was established based on characteristic histopathological findings.
- Confirmation was achieved using the Fite-Farraco stain, a specific method for identifying acid-fast bacilli like those causing leprosy.
- The co-occurrence of these conditions highlights potential diagnostic delays or complexities in endemic settings.
Implications:
- This case emphasizes the importance of considering leprosy in patients with pulmonary tuberculosis, especially in endemic areas.
- Accurate and timely diagnosis of both conditions is vital for appropriate treatment and preventing disease progression.
- Further research into the epidemiology and clinical presentation of concomitant TB and leprosy may improve diagnostic protocols.